A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer
This phase II trial studies how well radiation therapy with or without apalutamide works in
treating patients with stage III-IV prostate cancer. Radiation therapy uses high energy x-ray
to kill tumor cells and shrink tumors. Androgen can cause the growth of prostate cancer
cells. Drugs, such as apalutamide, may lessen the amount of androgen made by the body. Giving
radiation therapy and apalutamide may work better at treating prostate cancer than radiation
Lebanon,Southwestern Vermont,St. Johnsbury, VT
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.